Table 1.
Demographic Characteristics of 251 patients with Myasthenia Gravis assessed with the QMGS and the MGC
| Variable | Mean ± SD or n(%) |
| Sex (Female/Male) | 142(56.6%)/109(43.4%) |
| Age (years) | 57 ± 16.6 |
| Type (Ocular/Generalized) | 42(16.7%)/209(83.3%) |
| MGFA Remission | 9(3.6%) |
| MGFA MM | 12(4.8%) |
| MGFA I | 52(20.7%) |
| MGFA II | 145(57.8%) |
| MGFA III | 29(11.5%) |
| MGFA IV | 4(1.6%) |
| Disease Duration (months) | 103 ± 105 |
| Thymoma | 61(24.3%) |
| Thymectomy | 115(45.8%) |
| AchRAb (n = 90) | 63(70%) |
| QMGS total score | 7.6 ± 4.6 |
| MGC total score | 3.9 ± 4.3 |
MGFA: Myasthenia Gravis Foundation of America. MM: Minimal manifestation status. AchRAb: Acetylcholine receptor antibodies. QMGS: Quantitative Myasthenia Gravis Score. MGC: Myasthenia Gravis Composite.